AstraZeneca - ADR Peer Comparison
$168.37
$2.29
(1.38%)
As on 22-Sep-2026 16:00EDT
Market cap
$257,573 Mln
Revenue (TTM)
$61,366 Mln
P/E Ratio
24.9
P/B Ratio
5.1
Div. Yield
1.9 %
Edit
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
257,573 | 11,427 | 1,233 | 181,906 | 80,696 |
Revenue ($ Mln) |
61,366 | 29,432 | 57,743 | 98,861 | 124,905 |
Net Profit ($ Mln) |
10,446.00 | -621.00 | -8,956.01 | 8,600.00 | 11,200.00 |
Net Margin (%) |
17.02 | -2.11 | -15.51 | 8.70 | 8.97 |
RoE (%) |
21.11 | -5.35 | -9.71 | 7.29 | 12.46 |
Price to Earnings |
24.86 | 340.33 | -- | 22.09 | 7.34 |
Price-To-Book |
5.12 | 1.01 | 0.19 | 1.68 | 0.91 |
Income Statement ($ Mln)
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
61,366.00 | 29,432.00 | 57,743.08 | 98,861.00 | 124,905.00 |
|
Cost of Revenue
|
11,120.00 | 20,970.00 | 35,610.38 | 61,694.00 | 38,233.00 |
|
Gross Profit
|
48,106.00 | 9,776.00 | 22,483.42 | 35,659.00 | 88,756.00 |
|
Operating Expenses
|
36,275.00 | 20,142.00 | 15,948.22 | 21,345.00 | 68,358.00 |
|
Operating Profit (EBIT)
|
13,971.00 | -5,430.00 | 6,184.48 | 15,822.00 | 18,314.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
12,586.00 | -6,004.00 | -73.72 | 12,750.00 | 13,972.00 |
|
Provision for Tax
|
2,133.00 | -5,841.00 | 8,355.90 | 3,514.00 | 3,207.00 |
|
Profit after Tax (Net Income)
|
10,446.00 | -621.00 | -8,956.01 | 8,600.00 | 11,200.00 |
|
Minority Interest
|
-7.00 | -7.00 | -528.76 | -636.00 | 434.00 |
|
Consolidated Profit
|
4,859.00 | 0.00 | -9,962.53 | 3,715.00 | 0.00 |
Liabilities ($ Mln)
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
50,236.26 | 11,771.00 | 101,822.30 | 110,032.00 | 89,770.00 |
|
Minority Interest
|
-7.00 | -7.00 | -528.76 | -636.00 | 434.00 |
|
Non-Current Liabilities
|
33,870.40 | 21,001.00 | 96,959.00 | 52,793.00 | 134,500.00 |
|
Current Liabilities
|
31,516.15 | 10,600.00 | 27,246.40 | 35,105.00 | 33,093.00 |
|
Total Liabilities
|
114,074.00 | 43,342.00 | 229,262.20 | 197,514.00 | 272,631.00 |
Assets ($ Mln)
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
87,765.39 | 33,391.00 | 170,498.90 | 179,848.00 | 231,213.00 |
|
Current Assets
|
27,932.34 | 11,020.00 | 65,362.20 | 24,892.00 | 26,335.00 |
|
Total Assets
|
114,074.00 | 43,342.00 | 229,262.20 | 197,514.00 | 272,631.00 |
|
Total Debt*
|
32,201.35 | 15,156.00 | 87,811.60 | 46,041.00 | 90,381.00 |
|
Net Current Assets
|
-3,588.00 | 420.00 | 38,115.80 | -10,213.00 | -6,758.00 |
Cashflow ($ Mln)
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
14,575.00 | 485.00 | 23,195.21 | 18,101.00 | 33,643.00 |
|
Cash Flow from Investing Activities
|
-6,808.00 | -160.00 | -16,624.48 | -8,043.00 | -16,157.00 |
|
Cash from Financing Activities
|
-7,544.00 | -911.00 | -16,321.25 | -10,366.00 | -14,346.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.74 | -21.11 | -4.63 | 8.12 | 13.40 |
|
ROE (%)
|
21.11 | -5.35 | -9.71 | 7.29 | 12.46 |
|
ROA (%)
|
7.13 | -1.14 | -3.40 | 3.66 | 3.76 |
|
EBIT Margin (%)
|
23.34 | -16.85 | 16.14 | 17.90 | 14.71 |
|
Net Margin (%)
|
17.02 | -2.11 | -15.51 | 8.70 | 8.97 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
8.61 | 2.35 | -4.23 | 4.58 | 0.58 |
|
EBIT Growth (%)
|
22.42 | -461.44 | 426.29 | 37.89 | -42.21 |
|
Net Profit Growth (%)
|
25.93 | -4,335.71 | -6.90 | -25.55 | -51.10 |
|
EPS Growth (%)
|
25.89 | -2,128.64 | -29.24 | -24.02 | -49.13 |
|
Book Value Growth (%)
|
12.27 | -57.22 | 24.03 | 4.40 | -2.48 |
Valuation Ratios
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
14.00 | -2.40 | -0.15 | 16.72 | 5.43 |
|
Price / Book Value
|
2.95 | 1.27 | 0.01 | 1.89 | 1.12 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
8.45 | -5.36 | 1.91 | 12.91 | 4.52 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.47 | 1.23 | 0.79 | 0.34 | 0.94 |
|
Short term debt to equity ratio
|
0.12 | 0.06 | 0.02 | 0.08 | 0.07 |
|
Current Ratio
|
0.89 | 1.04 | 2.40 | 0.71 | 0.80 |
|
Quick Ratio
|
0.67 | 0.88 | 2.38 | 0.65 | 0.80 |
|
Interest Coverage
|
8.26 | -5.36 | 0.99 | 8.40 | 4.18 |
Operating Efficiency Ratios
| AstraZeneca - ADR | Paramount Skydance Corp Class B | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | Comcast Corporation Class A (CMCSA) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
26.02 | 20.99 | 31.28 | 14.72 | 11.17 |
|
Asset Turnover
|
0.42 | 0.54 | 0.22 | 0.42 | 0.42 |
|
Receivable days
|
82.12 | 84.61 | 73.28 | 50.18 | 40.64 |
|
Inventory Days
|
203.44 | 27.15 | 3.03 | 12.92 | -- |
|
Payable days
|
496.71 | 17.47 | 130.16 | 92.77 | 116.93 |
|
Cash Conversion Cycle
|
-211.15 | 94.30 | -53.86 | -29.67 | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
